Amino Collective
01 · Thesis & focus
Amino Collective is a health and bio venture firm founded in 2020 by Manuel Grossmann. It is based in Berlin, has an office in London, and is run as a solo-GP fund. It backs pre-seed and seed founders in computational and synthetic biology, AI drug discovery and digital health, mainly in Europe with some US deals. Fund I was €10M and Fund II closed at €30M.
02 · Recent publicly announced deals
Sensible Biotechnologies offers a cell-based mRNA design and manufacturing platform that focuses on producing pure, low immunogenicity mRNA, addressing the limitations of synthetic mRNA. The platform leverages advanced computational technologies in collaboration with NVIDIA to enhance the design and
Founders: Marian K., Miroslav G.London healthtech offering a health membership that combines clinicians, diagnostics and causal AI to build personalised health plans. Amino Collective led the round.
Founders: Alexander W., Reinhold I., Ben L.03 · Similar firms
Seedcamp£140k – £700k · Also Pre-seed · Healthcare & Wellbeing
Oxford Innovation EIS Growth Fund£150k – £400k · Also Pre-seed · Healthcare & Wellbeing
Techstarsup to £120k · Also Pre-seed · Healthcare & Wellbeing
Praetura Ventures£1M – £3.5M · Also Seed · Healthcare & Wellbeing
Kindred Capital£500k – £1.5M · Also Seed · Healthcare & Wellbeing
Ananda Impact Ventures£5M – £15M · Also Seed · Healthcare & Wellbeing
What looks wrong? We review every submission.
Prefer email? kudei@concept.vc
We re-check public sources and update stages, deals and fund news. Each card can be refreshed once a week.




